BioInformatics, LLC – the leading market research and advisory firm serving the life science industry – announces the publication of its latest report, “The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III.” Given the highly fragmented nature of the pre-made catalog antibodies market, this report is designed to create opportunities for differentiation […]
Blog
With hundreds of commercial suppliers of antibodies, selecting just the right antibody brings to mind the famous lock and key analogy of antibody-antigen binding—how do scientists find the perfect match? We first answered this question in 2004 and were then asked to update the answer in 2006. Now it’s time to revisit this important market […]
Interesting article here: NEW YORK (Fortune) — Biotechs working on cell treatments seem poised to profit from President Obama’s decision to lift the ban on federal funding for embryonic stem cell research and the $15 billion in stimulus money marked for scientific research. But for investors, the best way to play the sector might be […]
The market for stem cell research products is poised for explosive growth with the lifting of restrictions on federal funding. Whether you are an established player in the stem cell market or considering entry into this fast growing market, Capitalizing on New Opportunities for Stem Cell Products is an indispensable resource for: Corporate strategy Business […]
BioInformatics, LLC has been working with our good friend John Boyce in helping promote the First Annual Consumer Genetics Show in Boston this coming June. I first met John when he was working with Helicos and retained us to do a number of custom market research studies to help refine their market strategy. John’s new […]
As we all know, exhibiting at conferences has long been a common practice among life science vendors. Yet decisions on where to exhibit are often made with little more justification than the presence of competing vendors. Furthermore the nature of the promotional activities conducted at the conference are rarely tailored to the targeted audience. Whereas […]
Conferences play an essential role in fostering communication among life scientists. The most important role of conferences is to provide a forum for presenting cutting-edge research and important scientific developments. In addition, conferences offer scientists numerous opportunities for career advancement, networking, new collaborations and education. The rapid advances in life science have led to an […]
In my last few posts, I’ve been focusing on some of the challenges of advertising in the life science market and our approach to helping clients develop more effective ads. I’ll be honest here…I’m drumming up interest in our upcoming report on the subject: Advertising to Life Scientists: Resolving the Print vs. Online Dilemma. You […]
Life science suppliers seek to minimize risk when launching a product by gathering evidence that the product is likely to succeed. However, many suppliers still take a large risk when launching advertising campaigns without evidence the campaign will succeed with their target life science customers. Ad concept testing is a cost-saving solution that uses data […]
Well the holidays are over and I hope everyone has come back to work rested and refreshed. Here’s hoping for a happy and healthy new year for us all! In this post, I’d like to talk some more about print advertising in the life science market. Research that we’ve conducted reveals that 62% of scientists […]
Pay Invoice
Latest Blogs
-
The Strategic Edge: How Custom Competitive Intelligence (CI) Research Fuels Growth in Life Sciences
February 13, 2025 1:33 pm
-
Assessing the Value of Product Attributes: Deciphering Consumer Preferences
April 25, 2024 10:28 am
Sitemap
Your Data and Privacy
About Us
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.


